Basic information Safety Supplier Related

Osimertinib Impurity 28

Basic information Safety Supplier Related

Osimertinib Impurity 28 Basic information

Product Name:
Osimertinib Impurity 28
Synonyms:
  • Osimertinib Impurity 28
  • 2H6]-Osimertinib
  • N-[2-({2-[di(2H?)methylamino]ethyl}(methyl)amino)-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl]prop-2-enamide
  • D6-Osimertinib
CAS:
1638281-44-3
MF:
C28H33N7O2
MW:
499.62
Mol File:
1638281-44-3.mol
More
Less

Osimertinib Impurity 28 Chemical Properties

form 
Solid
color 
White to light yellow
More
Less

Osimertinib Impurity 28 Usage And Synthesis

Uses

Osimertinib-d6 is a deuterium labeled osimertinib. Osimertinib is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].

in vivo

Osimertinib (0.1-25 mg/kg; p.o.; daily for 14 day) induces significant dose-dependent regression in both PC-9 (ex19del) and H1975 (L858R/T790M) tumor xenograft models[1].

Animal Model:PC-9 (ex19del) and H1975 (L858R/T790M) tumor xenograft models[1]
Dosage:0.1-10 mg/kg (PC-9 xenograft models); 0.5- 25 mg/kg (H1975 xenograft models)
Administration:p.o.; daily for 14 day
Result:Induced significant dose-dependent regression in both PC-9 (ex19del) and H1975 (L858R/T790M) tumor xenograft models.

References

[1] Cross DA, et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 2014 Sep;4(9):1046-61. DOI:10.1158/2159-8290.CD-14-0337
[2] [2]Hirano T, et al. Pharmacological and Structural Characterizations of Naquotinib, a Novel Third-Generation EGFR Tyrosine Kinase Inhibitor, in EGFR-Mutated Non-Small Cell Lung Cancer. Mol Cancer Ther. 2018 Apr;17(4):740-750. DOI:10.1158/1535-7163.MCT-17-1033

Osimertinib Impurity 28Supplier

Daicel Chiral Technologies (China)CO.,LTD
Tel
021-50460086-9 15921403865
Email
han_yajun@dctc.daicel.com
Artis Biotech Co. Ltd.
Tel
028-67271278 18628360895
Email
sales@artisbio.com
BOC Sciences
Tel
+1-631-485-4226
Email
inquiry@bocsci.com
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-025-85560043 17301488900
Email
info@synzest.com
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15727060112
Email
yutianchun2007@126.com